Related Experiment Video
Updated: Jan 22, 2026

Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome
Published on: July 31, 2016
[The Cardiorenal Syndrome]
Insights
Peritoneal dialysis offers significant benefits for heart failure patients with refractory hypervolemia and kidney failure. This therapy complements standard treatments, improving outcomes in complex cardiorenal cases.
Area of Science:
- Cardiology
- Nephrology
- Renal Replacement Therapy
Background:
- Chronic heart failure (CHF) presents high morbidity and mortality, especially in elderly patients.
- Cardiorenal syndrome, involving kidney injury in heart failure, significantly worsens patient prognosis.
- Inhibiting the neurohumoral axis and managing hypervolemia are crucial in CHF treatment.
Purpose of the Study:
- To evaluate the role of peritoneal dialysis (PD) as an adjunctive therapy for heart failure patients.
- To assess the benefits of PD in cases of refractory hypervolemia and non-urinary renal failure.
- To explore PD's impact on outcomes in cardiorenal syndrome.
Main Methods:
- Review of current therapeutic options for heart failure with cardiorenal syndrome.
- Analysis of clinical data on patients undergoing PD as part of heart failure management.
- Comparison of outcomes between patients receiving PD and those on other therapies like hemodialysis or VAD implantation.
Main Results:
- Peritoneal dialysis demonstrates biological and clinical advantages in specific heart failure patient cohorts.
- PD effectively manages refractory hypervolemia, a common complication in advanced heart failure.
- The therapy is beneficial for patients with non-urinary renal failure secondary to cardiac conditions.
Conclusions:
- Peritoneal dialysis is a valuable additive therapy for heart failure patients experiencing refractory hypervolemia and renal failure.
- PD offers a viable treatment option, complementing conservative management and other interventions.
- Integrating PD can improve the management and outcomes of complex cardiorenal syndrome.
Abstract:
Chronic heart failure is associated with high morbidity and mortality and is the most common hospital diagnosis for elderly patients. Concomitant or superimposed acute or chronic kidney injury, as is the case with cardiorenal syndrome, has a dramatic impact on the outcome. The inhibition of the neurohumoral axis and the adequate treatment of hypervolemia are fundamental elements of modern cardiac insufficiency therapies. In addition to optimal conservative therapy, there are other options: VAD implantation, hemodialysis and peritoneal dialysis. The PD offers biological and clinical benefits as an additive therapy for the treatment of patients with heart failure, refractory hypervolemia and non-urinary renal failure.
More Related Videos
05:12Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome
Published on: September 19, 2019
09:39Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome
Published on: December 4, 2021
Related Concept Videos
Nephrotic Syndrome I : Introduction
Acute Coronary Syndrome I: Introduction
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Acute Coronary Syndrome V: Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management